{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:56:02Z","timestamp":1790650562587,"version":"4.1.0"},"publisher-location":"Cham","reference-count":142,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319596587","type":"print"},{"value":"9783319596594","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/164_2017_27","type":"book-chapter","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T12:50:25Z","timestamp":1491396625000},"page":"35-66","source":"Crossref","is-referenced-by-count":53,"title":["Comorbidities in Heart Failure"],"prefix":"10.1007","author":[{"given":"Haye H.","family":"van der Wal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent M.","family":"van Deursen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"van der Meer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan A.","family":"Voors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,6]]},"reference":[{"issue":"5","key":"27_CR1","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jchf.2014.12.013","volume":"3","author":"WT Abraham","year":"2015","unstructured":"Abraham WT, Jagielski D, Oldenburg O, Augostini R, Krueger S, Kolodziej A et al (2015) Phrenic nerve stimulation for the treatment of central sleep apnea. JACC Heart Fail 3(5):360\u2013369","journal-title":"JACC Heart Fail"},{"key":"27_CR2","unstructured":"Affymax and Takeda Announce a Nationwide Voluntary Recall of All Lots of OMONTYS\u00ae (peginesatide) Injection (2013) https:\/\/www.takeda.com\/news\/2013\/20130224_5664.html . Accessed 6 Dec 2015"},{"issue":"15","key":"27_CR3","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1001\/jama.2009.1493","volume":"302","author":"NM Albert","year":"2009","unstructured":"Albert NM, Yancy CW, Liang L, Zhao X, Hernandez AF, Peterson ED et al (2009) Use of aldosterone antagonists in heart failure. JAMA 302(15):1658\u20131665","journal-title":"JAMA"},{"issue":"5","key":"27_CR4","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1161\/CIRCHEARTFAILURE.115.002143","volume":"8","author":"U Alehagen","year":"2015","unstructured":"Alehagen U, Benson L, Edner M, Dahlstrom U, Lund LH (2015a) Association between use of statins and mortality in patients with heart failure and ejection fraction of \u226550. Circ Heart Fail 8(5):862\u2013870","journal-title":"Circ Heart Fail"},{"issue":"2","key":"27_CR5","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1161\/CIRCHEARTFAILURE.114.001730","volume":"8","author":"U Alehagen","year":"2015","unstructured":"Alehagen U, Benson L, Edner M, Dahlstrom U, Lund LH (2015b) Association between use of statins and outcomes in heart failure with reduced ejection fraction: prospective propensity score matched cohort study of 21 864 patients in the Swedish Heart Failure Registry. Circ Heart Fail 8(2):252\u2013260","journal-title":"Circ Heart Fail"},{"issue":"3","key":"27_CR6","first-page":"213","volume":"23","author":"L Amato","year":"1997","unstructured":"Amato L, Paolisso G, Cacciatore F, Ferrara N, Ferrara P, Canonico S et al (1997) Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly. The Osservatorio Geriatrico Regione Campania Group. Diabetes Metab 23(3):213\u2013218","journal-title":"Diabetes Metab"},{"issue":"25","key":"27_CR7","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","volume":"361","author":"SD Anker","year":"2009","unstructured":"Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H et al (2009) Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 361(25):2436\u20132448","journal-title":"N Engl J Med"},{"issue":"10","key":"27_CR8","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/ejhf.300","volume":"17","author":"SD Anker","year":"2015","unstructured":"Anker SD, Kosiborod M, Zannad F, Pina IL, McCullough PA, Filippatos G et al (2015) Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial. Eur J Heart Fail 17(10):1050\u20131056","journal-title":"Eur J Heart Fail"},{"issue":"25","key":"27_CR9","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1161\/CIRCULATIONAHA.106.683482","volume":"115","author":"M Arzt","year":"2007","unstructured":"Arzt M, Floras JS, Logan AG, Kimoff RJ, Series F, Morrison D et al (2007) Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian continuous positive airway pressure for patients with central sleep apnea and heart failure trial (CANPAP). Circulation 115(25):3173\u20133180","journal-title":"Circulation"},{"issue":"2","key":"27_CR10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jchf.2015.09.014","volume":"4","author":"M Arzt","year":"2016","unstructured":"Arzt M, Woehrle H, Oldenburg O, Graml A, Suling A, Erdmann E et al (2016) Prevalence and predictors of sleep-disordered breathing in patients with stable chronic heart failure: the SchlaHF registry. JACC Heart Fail 4(2):116\u2013125","journal-title":"JACC Heart Fail"},{"key":"27_CR11","doi-asserted-by":"publisher","unstructured":"Beldhuis IE, Streng KW, Ter Maaten JM, Voors AA, van der Meer P, Rossignol P et al (2017) Renin-angiotensin system inhibition, worsening renal function, and outcome in heart failure patients with reduced and preserved ejection fraction: a meta-analysis of published study data. Circ Heart Fail 10(2): 10.1161\/CIRCHEARTFAILURE.116.003588","DOI":"10.1161\/CIRCHEARTFAILURE.116.003588"},{"key":"27_CR12","doi-asserted-by":"crossref","unstructured":"Bonomini M, Del Vecchio L, Sirolli V, Locatelli F (2015) New treatment approaches for the anemia of CKD. Am J Kidney Dis","DOI":"10.1053\/j.ajkd.2015.06.030"},{"issue":"12","key":"27_CR13","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/01.CIR.0000061757.12581.15","volume":"107","author":"TD Bradley","year":"2003","unstructured":"Bradley TD, Floras JS (2003a) Sleep apnea and heart failure: part I: obstructive sleep apnea. Circulation 107(12):1671\u20131678","journal-title":"Circulation"},{"issue":"13","key":"27_CR14","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1161\/01.CIR.0000061758.05044.64","volume":"107","author":"TD Bradley","year":"2003","unstructured":"Bradley TD, Floras JS (2003b) Sleep apnea and heart failure: part II: central sleep apnea. Circulation 107(13):1822\u20131826","journal-title":"Circulation"},{"issue":"19","key":"27_CR15","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa051001","volume":"353","author":"TD Bradley","year":"2005","unstructured":"Bradley TD, Logan AG, Kimoff RJ, Series F, Morrison D, Ferguson K et al (2005) Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 353(19):2025\u20132033","journal-title":"N Engl J Med"},{"issue":"3","key":"27_CR16","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.ijcard.2012.12.083","volume":"168","author":"S Brenner","year":"2013","unstructured":"Brenner S, Guder G, Berliner D, Deubner N, Frohlich K, Ertl G et al (2013) Airway obstruction in systolic heart failure \u2013 COPD or congestion? Int J Cardiol 168(3):1910\u20131916","journal-title":"Int J Cardiol"},{"issue":"4","key":"27_CR17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/heartjnl-2011-300287","volume":"98","author":"S Brili","year":"2012","unstructured":"Brili S, Tousoulis D, Antonopoulos AS, Antoniades C, Hatzis G, Bakogiannis C et al (2012) Effects of atorvastatin on endothelial function and the expression of proinflammatory cytokines and adhesion molecules in young subjects with successfully repaired coarctation of aorta. Heart 98(4):325\u2013329","journal-title":"Heart"},{"key":"27_CR18","doi-asserted-by":"crossref","unstructured":"Chawla H, Tandon N (2017) Interpreting cardiovascular endpoints in trials of antihyperglycemic drugs. Am J Cardiovasc Drugs","DOI":"10.1007\/s40256-017-0215-6"},{"issue":"9","key":"27_CR19","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.amjcard.2005.11.059","volume":"97","author":"BR Choi","year":"2006","unstructured":"Choi BR, Kim JS, Yang YJ, Park KM, Lee CW, Kim YH et al (2006) Factors associated with decreased cerebral blood flow in congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 97(9):1365\u20131369","journal-title":"Am J Cardiol"},{"issue":"5","key":"27_CR20","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/1755-5922.12141","volume":"33","author":"VH Chong","year":"2015","unstructured":"Chong VH, Singh J, Parry H, Saunders J, Chowdhury F, Mancini DM et al (2015) Management of noncardiac comorbidities in chronic heart failure. Cardiovasc Ther 33(5):300\u2013315","journal-title":"Cardiovasc Ther"},{"issue":"3","key":"27_CR21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1076-7460.2007.06563.x","volume":"16","author":"MB Cohen","year":"2007","unstructured":"Cohen MB, Mather PJ (2007) A review of the association between congestive heart failure and cognitive impairment. Am J Geriatr Cardiol 16(3):171\u2013174","journal-title":"Am J Geriatr Cardiol"},{"issue":"18","key":"27_CR22","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1136\/heartjnl-2014-305669","volume":"100","author":"A Cohen-Solal","year":"2014","unstructured":"Cohen-Solal A, Leclercq C, Deray G, Lasocki S, Zambrowski JJ, Mebazaa A et al (2014) Iron deficiency: an emerging therapeutic target in heart failure. Heart 100(18):1414\u20131420","journal-title":"Heart"},{"issue":"10","key":"27_CR23","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/eurjhf\/hft083","volume":"15","author":"J Comin-Colet","year":"2013","unstructured":"Comin-Colet J, Enjuanes C, Gonzalez G, Torrens A, Cladellas M, Merono O et al (2013) Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status. Eur J Heart Fail 15(10):1164\u20131172","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"27_CR24","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1056\/NEJMoa1506459","volume":"373","author":"MR Cowie","year":"2015","unstructured":"Cowie MR, Woehrle H, Wegscheider K, Angermann C, d'Ortho MP, Erdmann E et al (2015) Adaptive servo-ventilation for central sleep apnea in systolic heart failure. N Eng J Med 373(12):1095\u20131105","journal-title":"N Eng J Med"},{"issue":"23","key":"27_CR25","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/eurheartj\/ehv010","volume":"36","author":"K Damman","year":"2015","unstructured":"Damman K, Testani JM (2015) The kidney in heart failure: an update. Eur Heart J 36(23):1437\u20131444","journal-title":"Eur Heart J"},{"issue":"9","key":"27_CR26","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ejheart.2007.05.010","volume":"9","author":"K Damman","year":"2007","unstructured":"Damman K, Navis G, Smilde TD, Voors AA, van der Bij W, van Veldhuisen DJ et al (2007) Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail 9(9):872\u2013878","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"27_CR27","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jacc.2008.08.080","volume":"53","author":"K Damman","year":"2009","unstructured":"Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL (2009) Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 53(7):582\u2013588","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"27_CR28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/eht386","volume":"35","author":"K Damman","year":"2014","unstructured":"Damman K, Valente MA, Voors AA, O\u2019Connor CM, van Veldhuisen DJ, Hillege HL (2014) Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J 35(7):455\u2013469","journal-title":"Eur Heart J"},{"issue":"8","key":"27_CR29","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ehj.2004.01.010","volume":"25","author":"P Groote De","year":"2004","unstructured":"De Groote P, Lamblin N, Mouquet F, Plichon D, McFadden E, Van Belle E et al (2004) Impact of diabetes mellitus on long-term survival in patients with congestive heart failure. Eur Heart J 25(8):656\u2013662","journal-title":"Eur Heart J"},{"issue":"10","key":"27_CR30","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.cardfail.2015.06.009","volume":"21","author":"GE Vries de","year":"2015","unstructured":"de Vries GE, van der Wal HH, Kerstjens HA, van Deursen VM, Stegenga B, van Veldhuisen DJ et al (2015) Validity and predictive value of a portable two-channel sleep-screening tool in the identification of sleep apnea in patients with heart failure. J Card Fail 21(10):848\u2013855","journal-title":"J Card Fail"},{"issue":"1","key":"27_CR31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1164\/ajrccm.151.1.7812578","volume":"151","author":"WA DeBacker","year":"1995","unstructured":"DeBacker WA, Verbraecken J, Willemen M, Wittesaele W, DeCock W, Van deHeyning P (1995) Central apnea index decreases after prolonged treatment with acetazolamide. Am J Respir Crit Care Med 151(1):87\u201391","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"27_CR32","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0954-6111(98)90136-6","volume":"92","author":"I Dimopoulou","year":"1998","unstructured":"Dimopoulou I, Daganou M, Tsintzas OK, Tzelepis GE (1998) Effects of severity of long-standing congestive heart failure on pulmonary function. Respir Med 92(12):1321\u20131325","journal-title":"Respir Med"},{"issue":"2","key":"27_CR33","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.amjmed.2012.05.029","volume":"126","author":"JA Dodson","year":"2013","unstructured":"Dodson JA, Truong TT, Towle VR, Kerins G, Chaudhry SI (2013) Cognitive impairment in older adults with heart failure: prevalence, documentation, and impact on outcomes. Am J Med 126(2):120\u2013126","journal-title":"Am J Med"},{"issue":"2","key":"27_CR34","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijcard.2014.03.169","volume":"174","author":"C Enjuanes","year":"2014","unstructured":"Enjuanes C, Klip IT, Bruguera J, Cladellas M, Ponikowski P, Banasiak W et al (2014) Iron deficiency and health-related quality of life in chronic heart failure: results from a multicenter European study. Int J Cardiol 174(2):268\u2013275","journal-title":"Int J Cardiol"},{"issue":"11 Suppl","key":"27_CR35","first-page":"S212","volume":"21","author":"M Epstein","year":"2015","unstructured":"Epstein M, Reaven NL, Funk SE, McGaughey KJ, Oestreicher N, Knispel J (2015) Evaluation of the treatment gap between clinical guidelines and the utilization of renin-angiotensin-aldosterone system inhibitors. Am J Manag Care 21(11 Suppl):S212\u2013S220","journal-title":"Am J Manag Care"},{"key":"27_CR36","doi-asserted-by":"crossref","unstructured":"Erkelens CD, van der Wal HH, de Jong BM, Elting JW, Renken R, Gerritsen M et al (2016) Dynamics of cerebral blood flow in patients with mild non-ischaemic heart failure. Eur J Heart Fail","DOI":"10.1002\/ejhf.660"},{"issue":"2","key":"27_CR37","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1172\/JCI72227","volume":"124","author":"E Ferrannini","year":"2014","unstructured":"Ferrannini E, Muscelli E, Frascerra S, Baldi S, Mari A, Heise T et al (2014) Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients. J Clin Invest 124(2):499\u2013508","journal-title":"J Clin Invest"},{"issue":"18","key":"27_CR38","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1182\/blood-2009-05-224808","volume":"115","author":"KE Finberg","year":"2010","unstructured":"Finberg KE, Whittlesey RL, Fleming MD, Andrews NC (2010) Down-regulation of Bmp\/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis. Blood 115(18):3817\u20133826","journal-title":"Blood"},{"issue":"19","key":"27_CR39","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1093\/eurheartj\/ehv728","volume":"37","author":"D Fitchett","year":"2016","unstructured":"Fitchett D, Zinman B, Wanner C, Lachin JM, Hantel S, Salsali A et al (2016) Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME(R) trial. Eur Heart J 37(19):1526\u20131534","journal-title":"Eur Heart J"},{"issue":"11","key":"27_CR40","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.amjcard.2011.01.060","volume":"107","author":"M Fontana","year":"2011","unstructured":"Fontana M, Emdin M, Giannoni A, Iudice G, Baruah R, Passino C (2011) Effect of acetazolamide on chemosensitivity, Cheyne-Stokes respiration, and response to effort in patients with heart failure. Am J Cardiol 107(11):1675\u20131680","journal-title":"Am J Cardiol"},{"issue":"4","key":"27_CR41","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1152\/physrev.00008.2013","volume":"93","author":"T Ganz","year":"2013","unstructured":"Ganz T (2013) Systemic iron homeostasis. Physiol Rev 93(4):1721\u20131741","journal-title":"Physiol Rev"},{"issue":"4","key":"27_CR42","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1203858","volume":"367","author":"HC Gerstein","year":"2012","unstructured":"Gerstein HC, Bosch J, Dagenais GR, Diaz R, Jung H, ORIGIN Trial Investigators et al (2012) Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med 367(4):319\u2013328","journal-title":"N Engl J Med"},{"issue":"9645","key":"27_CR43","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(08)61240-4","volume":"372","author":"L Tavazzi","year":"2008","unstructured":"Gissi-HF Investigators, Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG et al (2008) Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 372(9645):1231\u20131239","journal-title":"Lancet"},{"issue":"5","key":"27_CR44","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/ajcn\/71.5.1033","volume":"71","author":"HR Gosker","year":"2000","unstructured":"Gosker HR, Wouters EF, van der Vusse GJ, Schols AM (2000) Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr 71(5):1033\u20131047","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"27_CR45","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1054\/jcaf.2002.125289","volume":"8","author":"SS Gottlieb","year":"2002","unstructured":"Gottlieb SS, Abraham W, Butler J, Forman DE, Loh E, Massie BM et al (2002) The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail 8(3):136\u2013141","journal-title":"J Card Fail"},{"issue":"2","key":"27_CR46","doi-asserted-by":"crossref","first-page":"277.e1","DOI":"10.1016\/j.ahj.2007.05.001","volume":"154","author":"BH Greenberg","year":"2007","unstructured":"Greenberg BH, Abraham WT, Albert NM, Chiswell K, Clare R, Stough WG et al (2007) Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J 154(2):277.e1\u2013277.e8","journal-title":"Am Heart J"},{"issue":"10","key":"27_CR47","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jacc.2008.04.061","volume":"52","author":"HF Groenveld","year":"2008","unstructured":"Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ et al (2008) Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol 52(10):818\u2013827","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"27_CR48","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/ejhf.183","volume":"16","author":"G Guder","year":"2014","unstructured":"Guder G, Brenner S, Stork S, Hoes A, Rutten FH (2014) Chronic obstructive pulmonary disease in heart failure: accurate diagnosis and treatment. Eur J Heart Fail 16(12):1273\u20131282","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"27_CR49","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/eurjhf\/hfq002","volume":"12","author":"VP Harjola","year":"2010","unstructured":"Harjola VP, Follath F, Nieminen MS, Brutsaert D, Dickstein K, Drexler H et al (2010) Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure. Eur J Heart Fail 12(3):239\u2013248","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"27_CR50","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/eurjhf\/hfn013","volume":"11","author":"NM Hawkins","year":"2009","unstructured":"Hawkins NM, Petrie MC, Jhund PS, Chalmers GW, Dunn FG, McMurray JJ (2009) Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail 11(2):130\u2013139","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"27_CR51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/eurjhf\/hfp160","volume":"12","author":"NM Hawkins","year":"2010","unstructured":"Hawkins NM, Jhund PS, Simpson CR, Petrie MC, Macdonald MR, Dunn FG et al (2010) Primary care burden and treatment of patients with heart failure and chronic obstructive pulmonary disease in Scotland. Eur J Heart Fail 12(1):17\u201324","journal-title":"Eur J Heart Fail"},{"issue":"36","key":"27_CR52","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1093\/eurheartj\/eht192","volume":"34","author":"NM Hawkins","year":"2013","unstructured":"Hawkins NM, Virani S, Ceconi C (2013) Heart failure and chronic obstructive pulmonary disease: the challenges facing physicians and health services. Eur Heart J 34(36):2795\u20132803","journal-title":"Eur Heart J"},{"issue":"7","key":"27_CR53","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/eurjhf\/hfq050","volume":"12","author":"KK Iversen","year":"2010","unstructured":"Iversen KK, Kjaergaard J, Akkan D, Kober L, Torp-Pedersen C, Hassager C et al (2010) The prognostic importance of lung function in patients admitted with heart failure. Eur J Heart Fail 12(7):685\u2013691","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"27_CR54","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.sleep.2015.01.008","volume":"16","author":"M Jackson","year":"2015","unstructured":"Jackson M, Collins A, Berlowitz D, Howard M, O\u2019Donoghue F, Barnes M (2015) Efficacy of sleep position modification to treat positional obstructive sleep apnea. Sleep Med 16(4):545\u2013552","journal-title":"Sleep Med"},{"issue":"11","key":"27_CR55","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/ejhf.593","volume":"18","author":"D Jagielski","year":"2016","unstructured":"Jagielski D, Ponikowski P, Augostini R, Kolodziej A, Khayat R, Abraham WT (2016) Transvenous stimulation of the phrenic nerve for the treatment of central sleep apnoea: 12 months\u2019 experience with the remede(R) system. Eur J Heart Fail 18(11):1386\u20131393","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"27_CR56","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nrd1901","volume":"4","author":"MK Jain","year":"2005","unstructured":"Jain MK, Ridker PM (2005) Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov 4(12):977\u2013987","journal-title":"Nat Rev Drug Discov"},{"issue":"15","key":"27_CR57","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/eurheartj\/ehq158","volume":"31","author":"EA Jankowska","year":"2010","unstructured":"Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B et al (2010) Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J 31(15):1872\u20131880","journal-title":"Eur Heart J"},{"issue":"11","key":"27_CR58","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.cardfail.2011.08.003","volume":"17","author":"EA Jankowska","year":"2011","unstructured":"Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B et al (2011) Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure. J Card Fail 17(11):899\u2013906","journal-title":"J Card Fail"},{"issue":"11","key":"27_CR59","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/eurheartj\/ehs224","volume":"34","author":"EA Jankowska","year":"2013","unstructured":"Jankowska EA, von Haehling S, Anker SD, Macdougall IC, Ponikowski P (2013a) Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives. Eur Heart J 34(11):816\u2013829","journal-title":"Eur Heart J"},{"issue":"11","key":"27_CR60","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/eurheartj\/ehs377","volume":"34","author":"EA Jankowska","year":"2013","unstructured":"Jankowska EA, Malyszko J, Ardehali H, Koc-Zorawska E, Banasiak W, von Haehling S et al (2013b) Iron status in patients with chronic heart failure. Eur Heart J 34(11):827\u2013834","journal-title":"Eur Heart J"},{"issue":"36","key":"27_CR61","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1093\/eurheartj\/ehu235","volume":"35","author":"EA Jankowska","year":"2014","unstructured":"Jankowska EA, Kasztura M, Sokolski M, Bronisz M, Nawrocka S, Oleskowska-Florek W et al (2014) Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure. Eur Heart J 35(36):2468\u20132476","journal-title":"Eur Heart J"},{"issue":"2","key":"27_CR62","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1164\/rccm.200507-1035OC","volume":"173","author":"S Javaheri","year":"2006","unstructured":"Javaheri S (2006) Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study. Am J Respir Crit Care Med 173(2):234\u2013237","journal-title":"Am J Respir Crit Care Med"},{"issue":"21","key":"27_CR63","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.97.21.2154","volume":"97","author":"S Javaheri","year":"1998","unstructured":"Javaheri S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, Wexler L et al (1998) Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 97(21):2154\u20132159","journal-title":"Circulation"},{"issue":"5","key":"27_CR64","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1164\/rccm.201503-0536OC","volume":"193","author":"S Javaheri","year":"2016","unstructured":"Javaheri S, Blackwell T, Ancoli-Israel S, Ensrud KE, Stone KL, Redline S et al (2016) Sleep-disordered breathing and incident heart failure in older men. Am J Respir Crit Care Med 193(5):561\u2013568","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"27_CR65","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ejhf.657","volume":"19","author":"A Jorsal","year":"2017","unstructured":"Jorsal A, Kistorp C, Holmager P, Tougaard RS, Nielsen R, Hanselmann A et al (2017) Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial. Eur J Heart Fail 19(1):69\u201377","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"27_CR66","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1464-5491.2005.01704.x","volume":"22","author":"AJ Karter","year":"2005","unstructured":"Karter AJ, Ahmed AT, Liu J, Moffet HH, Parker MM (2005) Pioglitazone initiation and subsequent hospitalization for congestive heart failure. Diabet Med 22(8):986\u2013993","journal-title":"Diabet Med"},{"issue":"22","key":"27_CR67","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1056\/NEJMoa0706201","volume":"357","author":"J Kjekshus","year":"2007","unstructured":"Kjekshus J, Apetrei E, Barrios V, Bohm M, Cleland JG, Cornel JH et al (2007) Rosuvastatin in older patients with systolic heart failure. N Engl J Med 357(22):2248\u20132261","journal-title":"N Engl J Med"},{"issue":"4","key":"27_CR68","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","volume":"165","author":"IT Klip","year":"2013","unstructured":"Klip IT, Comin-Colet J, Voors AA, Ponikowski P, Enjuanes C, Banasiak W et al (2013) Iron deficiency in chronic heart failure: an international pooled analysis. Am Heart J 165(4):575\u2013582.e3","journal-title":"Am Heart J"},{"issue":"6","key":"27_CR69","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ejhf.84","volume":"16","author":"IT Klip","year":"2014","unstructured":"Klip IT, Jankowska EA, Enjuanes C, Voors AA, Banasiak W, Bruguera J et al (2014) The additive burden of iron deficiency in the cardiorenal-anaemia axis: scope of a problem and its consequences. Eur J Heart Fail 16(6):655\u2013662","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"27_CR70","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ahj.2014.09.010","volume":"169","author":"IT Klip","year":"2015","unstructured":"Klip IT, Postmus D, Voors AA, Brouwers FP, Gansevoort RT, Bakker SJ et al (2015) Hemoglobin levels and new-onset heart failure in the community. Am Heart J 169(1):94\u2013101.e2","journal-title":"Am Heart J"},{"issue":"7","key":"27_CR71","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/eurheartj\/ehp604","volume":"31","author":"M Komajda","year":"2010","unstructured":"Komajda M, McMurray JJ, Beck-Nielsen H, Gomis R, Hanefeld M, Pocock SJ et al (2010) Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial. Eur Heart J 31(7):824\u2013831","journal-title":"Eur Heart J"},{"key":"27_CR72","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijcard.2016.02.146","volume":"211","author":"J Kongwatcharapong","year":"2016","unstructured":"Kongwatcharapong J, Dilokthornsakul P, Nathisuwan S, Phrommintikul A, Chaiyakunapruk N (2016) Effect of dipeptidyl peptidase-4 inhibitors on heart failure: a meta-analysis of randomized clinical trials. Int J Cardiol 211:88\u201395","journal-title":"Int J Cardiol"},{"issue":"21","key":"27_CR73","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1001\/jama.2014.15688","volume":"312","author":"M Kosiborod","year":"2014","unstructured":"Kosiborod M, Rasmussen HS, Lavin P, Qunibi WY, Spinowitz B, Packham D et al (2014) Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial. JAMA 312(21):2223\u20132233","journal-title":"JAMA"},{"issue":"4","key":"27_CR74","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1177\/1479164115579006","volume":"12","author":"CS Lam","year":"2015","unstructured":"Lam CS (2015) Diabetic cardiomyopathy: an expression of stage B heart failure with preserved ejection fraction. Diab Vasc Dis Res 12(4):234\u2013238","journal-title":"Diab Vasc Dis Res"},{"issue":"8","key":"27_CR75","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/europace\/eur128","volume":"13","author":"J Lamba","year":"2011","unstructured":"Lamba J, Simpson CS, Redfearn DP, Michael KA, Fitzpatrick M, Baranchuk A (2011) Cardiac resynchronization therapy for the treatment of sleep apnoea: a meta-analysis. Europace 13(8):1174\u20131179","journal-title":"Europace"},{"key":"27_CR76","doi-asserted-by":"publisher","unstructured":"Lewis GD, Semigran MJ, Givertz MM, Malhotra R, Anstrom KJ, Hernandez AF et al (2016) Oral iron therapy for heart failure with reduced ejection fraction: design and rationale for oral iron repletion effects on oxygen uptake in heart failure. Circ Heart Fail 9(5): 10.1161\/CIRCHEARTFAILURE.115.000345","DOI":"10.1161\/CIRCHEARTFAILURE.115.000345"},{"key":"27_CR77","doi-asserted-by":"crossref","first-page":"i610","DOI":"10.1136\/bmj.i610","volume":"352","author":"L Li","year":"2016","unstructured":"Li L, Li S, Deng K, Liu J, Vandvik PO, Zhao P et al (2016) Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies. BMJ 352:i610","journal-title":"BMJ"},{"issue":"Suppl 4","key":"27_CR78","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2165\/00003495-199000394-00004","volume":"39","author":"S Ljungman","year":"1990","unstructured":"Ljungman S, Laragh JH, Cody RJ (1990) Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function. Drugs 39(Suppl 4):10\u201321. Discussion 22\u20134","journal-title":"Drugs"},{"issue":"11","key":"27_CR79","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1046\/j.1440-1681.1999.03165.x","volume":"26","author":"JD Luo","year":"1999","unstructured":"Luo JD, Zhang WW, Zhang GP, Guan JX, Chen X (1999) Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis. Clin Exp Pharmacol Physiol 26(11):903\u2013908","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"7","key":"27_CR80","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.cjca.2015.04.017","volume":"31","author":"OD Lyons","year":"2015","unstructured":"Lyons OD, Bradley TD (2015) Heart failure and sleep apnea. Can J Cardiol 31(7):898\u2013908","journal-title":"Can J Cardiol"},{"issue":"11","key":"27_CR81","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/eurheartj\/ehn153","volume":"29","author":"MR MacDonald","year":"2008","unstructured":"MacDonald MR, Petrie MC, Varyani F, Ostergren J, Michelson EL, Young JB et al (2008) Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. Eur Heart J 29(11):1377\u20131385","journal-title":"Eur Heart J"},{"issue":"6","key":"27_CR82","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2337\/dc09-2227","volume":"33","author":"MR MacDonald","year":"2010","unstructured":"MacDonald MR, Eurich DT, Majumdar SR, Lewsey JD, Bhagra S, Jhund PS et al (2010) Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. general practice research database. Diabetes Care 33(6):1213\u20131218","journal-title":"Diabetes Care"},{"issue":"4","key":"27_CR83","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMoa1203166","volume":"368","author":"IC Macdougall","year":"2013","unstructured":"Macdougall IC, Provenzano R, Sharma A, Spinowitz BS, Schmidt RJ, Pergola PE et al (2013) Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis. N Engl J Med 368(4):320\u2013332","journal-title":"N Engl J Med"},{"issue":"10","key":"27_CR84","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/eurjhf\/hft134","volume":"15","author":"AP Maggioni","year":"2013","unstructured":"Maggioni AP, Anker SD, Dahlstrom U, Filippatos G, Ponikowski P, Zannad F et al (2013) Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail 15(10):1173\u20131184","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"27_CR85","first-page":"CD003235","volume":"2","author":"BA Mahoney","year":"2005","unstructured":"Mahoney BA, Smith WA, Lo DS, Tsoi K, Tonelli M, Clase CM (2005) Emergency interventions for hyperkalaemia. Cochrane Database Syst Rev 2(2):CD003235","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"27_CR86","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA et al (2016a) Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med 375(4):311\u2013322","journal-title":"N Engl J Med"},{"issue":"19","key":"27_CR87","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jodar E, Leiter LA et al (2016b) Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med 375(19):1834\u20131844","journal-title":"N Engl J Med"},{"issue":"21","key":"27_CR88","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.jacc.2014.08.036","volume":"64","author":"RJ Mentz","year":"2014","unstructured":"Mentz RJ, Kelly JP, von Lueder TG, Voors AA, Lam CS, Cowie MR et al (2014) Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol 64(21):2281\u20132293","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"27_CR89","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/thoraxjnl-2011-200927","volume":"67","author":"MT Naughton","year":"2012","unstructured":"Naughton MT (2012) Cheyne-Stokes respiration: friend or foe? Thorax 67(4):357\u2013360","journal-title":"Thorax"},{"issue":"1","key":"27_CR90","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/dmrr.480","volume":"21","author":"GA Nichols","year":"2005","unstructured":"Nichols GA, Koro CE, Gullion CM, Ephross SA, Brown JB (2005) The incidence of congestive heart failure associated with antidiabetic therapies. Diabetes Metab Res Rev 21(1):51\u201357","journal-title":"Diabetes Metab Res Rev"},{"issue":"8","key":"27_CR91","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.cardfail.2015.05.006","volume":"21","author":"ED Niehaus","year":"2015","unstructured":"Niehaus ED, Malhotra R, Cocca-Spofford D, Semigran M, Lewis GD (2015) Repletion of iron stores with the use of oral iron supplementation in patients with systolic heart failure. J Card Fail 21(8):694\u2013697","journal-title":"J Card Fail"},{"issue":"3","key":"27_CR92","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejheart.2006.08.003","volume":"9","author":"O Oldenburg","year":"2007","unstructured":"Oldenburg O, Lamp B, Faber L, Teschler H, Horstkotte D, Topfer V (2007) Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail 9(3):251\u2013257","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"27_CR93","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1411487","volume":"372","author":"DK Packham","year":"2015","unstructured":"Packham DK, Rasmussen HS, Lavin PT, El-Shahawy MA, Roger SD, Block G et al (2015) Sodium zirconium cyclosilicate in hyperkalemia. N Engl J Med 372(3):222\u2013231","journal-title":"N Engl J Med"},{"issue":"9","key":"27_CR94","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.sleep.2014.11.022","volume":"16","author":"J Parisot","year":"2015","unstructured":"Parisot J, Damy T, Gellen B, Covali-Noroc A, Bodez D, Rappeneau S et al (2015) Sleep-disordered breathing in chronic heart failure: development and validation of a clinical screening score. Sleep Med 16(9):1094\u20131101","journal-title":"Sleep Med"},{"issue":"1","key":"27_CR95","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijcard.2011.11.098","volume":"157","author":"JT Parissis","year":"2012","unstructured":"Parissis JT, Rafouli-Stergiou P, Mebazaa A, Ikonomidis I, Bistola V, Nikolaou M et al (2012) Acute heart failure in patients with diabetes mellitus: clinical characteristics and predictors of in-hospital mortality. Int J Cardiol 157(1):108\u2013113","journal-title":"Int J Cardiol"},{"issue":"23","key":"27_CR96","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1509225","volume":"373","author":"MA Pfeffer","year":"2015","unstructured":"Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Kober LV et al (2015a) Lixisenatide in patients with type 2 diabetes and acute coronary syndrome. N Engl J Med 373(23):2247\u20132257","journal-title":"N Engl J Med"},{"issue":"23","key":"27_CR97","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1509225","volume":"373","author":"MA Pfeffer","year":"2015","unstructured":"Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Kober LV et al (2015b) Lixisenatide in patients with type 2 diabetes and acute coronary syndrome. N Engl J Med 373(23):2247\u20132257","journal-title":"N Engl J Med"},{"issue":"12","key":"27_CR98","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/ejhf.410","volume":"17","author":"GD Pinna","year":"2015","unstructured":"Pinna GD, Robbi E, La Rovere MT, Taurino AE, Bruschi C, Guazzotti G et al (2015) Differential impact of body position on the severity of disordered breathing in heart failure patients with obstructive vs. central sleep apnoea. Eur J Heart Fail 17(12):1302\u20131309","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"27_CR99","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/eurheartj\/ehq502","volume":"32","author":"B Pitt","year":"2011","unstructured":"Pitt B, Anker SD, Bushinsky DA, Kitzman DW, Zannad F, Huang IZ et al (2011) Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial. Eur Heart J 32(7):820\u2013828","journal-title":"Eur Heart J"},{"issue":"10","key":"27_CR100","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/ejhf.402","volume":"17","author":"B Pitt","year":"2015","unstructured":"Pitt B, Bakris GL, Bushinsky DA, Garza D, Mayo MR, Stasiv Y et al (2015) Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors. Eur J Heart Fail 17(10):1057\u20131065","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"27_CR101","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jacc.2006.11.024","volume":"49","author":"P Ponikowski","year":"2007","unstructured":"Ponikowski P, Anker SD, Szachniewicz J, Okonko D, Ledwidge M, Zymlinski R et al (2007) Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol 49(7):753\u2013762","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"27_CR102","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","volume":"36","author":"P Ponikowski","year":"2015","unstructured":"Ponikowski P, van Veldhuisen DJ, Comin-Colet J, Ertl G, Komajda M, Mareev V et al (2015) Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur Heart J 36(11):657\u2013668","journal-title":"Eur Heart J"},{"key":"27_CR103","doi-asserted-by":"crossref","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ et al (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J","DOI":"10.1093\/eurheartj\/ehw128"},{"issue":"3","key":"27_CR104","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/01.JCN.0000305096.09710.ec","volume":"23","author":"SJ Pressler","year":"2008","unstructured":"Pressler SJ (2008) Cognitive functioning and chronic heart failure: a review of the literature (2002-July 2007). J Cardiovasc Nurs 23(3):239\u2013249","journal-title":"J Cardiovasc Nurs"},{"issue":"6","key":"27_CR105","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1053\/j.ajkd.2015.12.020","volume":"67","author":"R Provenzano","year":"2016","unstructured":"Provenzano R, Besarab A, Wright S, Dua S, Zeig S, Nguyen P et al (2016) Roxadustat (FG-4592) versus Epoetin Alfa for anemia in patients receiving maintenance hemodialysis: a phase 2, randomized, 6- to 19-week, open-label, active-comparator, dose-ranging, safety and exploratory efficacy study. Am J Kidney Dis 67(6):912\u2013924","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"27_CR106","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1053\/jscd.2001.26870","volume":"10","author":"P Pullicino","year":"2001","unstructured":"Pullicino P, Mifsud V, Wong E, Graham S, Ali I, Smajlovic D (2001) Hypoperfusion-related cerebral ischemia and cardiac left ventricular systolic dysfunction. J Stroke Cerebrovasc Dis 10(4):178\u2013182","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"3","key":"27_CR107","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jchf.2013.12.007","volume":"2","author":"JK Rogers","year":"2014","unstructured":"Rogers JK, Jhund PS, Perez AC, Bohm M, Cleland JG, Gullestad L et al (2014) Effect of rosuvastatin on repeat heart failure hospitalizations: the CORONA trial (controlled Rosuvastatin multinational trial in heart failure). JACC Heart Fail 2(3):289\u2013297","journal-title":"JACC Heart Fail"},{"key":"27_CR108","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2147\/VHRM.S34874","volume":"8","author":"AE Roher","year":"2012","unstructured":"Roher AE, Debbins JP, Malek-Ahmadi M, Chen K, Pipe JG, Maze S et al (2012) Cerebral blood flow in Alzheimer\u2019s disease. Vasc Health Risk Manag 8:599\u2013611","journal-title":"Vasc Health Risk Manag"},{"key":"27_CR109","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ijcard.2016.11.181","volume":"228","author":"M Saad","year":"2017","unstructured":"Saad M, Mahmoud AN, Elgendy IY, Abuzaid A, Barakat AF, Elgendy AY et al (2017) Cardiovascular outcomes with sodium-glucose cotransporter-2 inhibitors in patients with type II diabetes mellitus: a meta-analysis of placebo-controlled randomized trials. Int J Cardiol 228:352\u2013358","journal-title":"Int J Cardiol"},{"issue":"8","key":"27_CR110","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.rmed.2010.01.020","volume":"104","author":"R Sabit","year":"2010","unstructured":"Sabit R, Bolton CE, Fraser AG, Edwards JM, Edwards PH, Ionescu AA et al (2010) Sub-clinical left and right ventricular dysfunction in patients with COPD. Respir Med 104(8):1171\u20131178","journal-title":"Respir Med"},{"issue":"2","key":"27_CR111","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/eurjhf\/hfs153","volume":"15","author":"S Sarma","year":"2013","unstructured":"Sarma S, Mentz RJ, Kwasny MJ, Fought AJ, Huffman M, Subacius H et al (2013) Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial. Eur J Heart Fail 15(2):194\u2013202","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"27_CR112","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1080\/13543784.2016.1182981","volume":"25","author":"H Schmid","year":"2016","unstructured":"Schmid H, Jelkmann W (2016) Investigational therapies for renal disease-induced anemia. Expert Opin Investig Drugs 25(8):901\u2013916","journal-title":"Expert Opin Investig Drugs"},{"issue":"27","key":"27_CR113","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1093\/eurheartj\/ehv134","volume":"36","author":"PM Seferovic","year":"2015","unstructured":"Seferovic PM, Paulus WJ (2015) Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes. Eur Heart J 36(27):1718\u20131727. 1727a-1727c","journal-title":"Eur Heart J"},{"issue":"2","key":"27_CR114","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/ki.1997.77","volume":"51","author":"GL Semenza","year":"1997","unstructured":"Semenza GL, Agani F, Booth G, Forsythe J, Iyer N, Jiang BH et al (1997) Structural and functional analysis of hypoxia-inducible factor 1. Kidney Int 51(2):553\u2013555","journal-title":"Kidney Int"},{"issue":"12","key":"27_CR115","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1161\/01.CIR.0000143547.55093.17","volume":"110","author":"MG Shlipak","year":"2004","unstructured":"Shlipak MG, Massie BM (2004) The clinical challenge of cardiorenal syndrome. Circulation 110(12):1514\u20131517","journal-title":"Circulation"},{"issue":"7","key":"27_CR116","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S0735-1097(00)00613-6","volume":"35","author":"DS Silverberg","year":"2000","unstructured":"Silverberg DS, Wexler D, Blum M, Keren G, Sheps D, Leibovitch E et al (2000) The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol 35(7):1737\u20131744","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"27_CR117","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0735-1097(01)01248-7","volume":"37","author":"DS Silverberg","year":"2001","unstructured":"Silverberg DS, Wexler D, Sheps D, Blum M, Keren G, Baruch R et al (2001) The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol 37(7):1775\u20131780","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"27_CR118","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1164\/ajrccm.160.4.9903020","volume":"160","author":"DD Sin","year":"1999","unstructured":"Sin DD, Fitzgerald F, Parker JD, Newton G, Floras JS, Bradley TD (1999) Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 160(4):1101\u20131106","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"27_CR119","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00392-008-0732-z","volume":"98","author":"TD Smilde","year":"2009","unstructured":"Smilde TD, Damman K, van der Harst P, Navis G, Westenbrink BD, Voors AA et al (2009) Differential associations between renal function and \u201cmodifiable\u201d risk factors in patients with chronic heart failure. Clin Res Cardiol 98(2):121\u2013129","journal-title":"Clin Res Cardiol"},{"issue":"13","key":"27_CR120","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa1214865","volume":"368","author":"K Swedberg","year":"2013","unstructured":"Swedberg K, Young JB, Anand IS, Cheng S, Desai AS, Diaz R et al (2013) Treatment of anemia with darbepoetin alfa in systolic heart failure. N Engl J Med 368(13):1210\u20131219","journal-title":"N Engl J Med"},{"issue":"20","key":"27_CR121","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1161\/CIRCULATIONAHA.105.583666","volume":"113","author":"YD Tang","year":"2006","unstructured":"Tang YD, Katz SD (2006) Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options. Circulation 113(20):2454\u20132461","journal-title":"Circulation"},{"issue":"11","key":"27_CR122","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.amjcard.2016.08.061","volume":"118","author":"H Tang","year":"2016","unstructured":"Tang H, Fang Z, Wang T, Cui W, Zhai S, Song Y (2016) Meta-analysis of effects of sodium-glucose Cotransporter 2 inhibitors on cardiovascular outcomes and all-cause mortality among patients with type 2 diabetes mellitus. Am J Cardiol 118(11):1774\u20131780","journal-title":"Am J Cardiol"},{"issue":"4","key":"27_CR123","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0002-9343(02)01530-9","volume":"114","author":"A Tenenbaum","year":"2003","unstructured":"Tenenbaum A, Motro M, Fisman EZ, Leor J, Freimark D, Boyko V et al (2003) Functional class in patients with heart failure is associated with the development of diabetes. Am J Med 114(4):271\u2013275","journal-title":"Am J Med"},{"issue":"12","key":"27_CR124","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/eurjhf\/hfr138","volume":"13","author":"K Hurk van den","year":"2011","unstructured":"van den Hurk K, Reijmer YD, van den Berg E, Alssema M, Nijpels G, Kostense PJ et al (2011) Heart failure and cognitive function in the general population: the Hoorn study. Eur J Heart Fail 13(12):1362\u20131369","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"27_CR125","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ehj.2003.11.017","volume":"25","author":"P Meer van der","year":"2004","unstructured":"van der Meer P, Voors AA, Lipsic E, van Gilst WH, van Veldhuisen DJ (2004) Erythropoietin in cardiovascular diseases. Eur Heart J 25(4):285\u2013291","journal-title":"Eur Heart J"},{"issue":"12","key":"27_CR126","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1161\/CIRCULATIONAHA.105.549121","volume":"112","author":"P Meer van der","year":"2005","unstructured":"van der Meer P, Lipsic E, Westenbrink BD, van de Wal RM, Schoemaker RG, Vellenga E et al (2005) Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure. Circulation 112(12):1743\u20131747","journal-title":"Circulation"},{"issue":"11","key":"27_CR127","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1080\/14656566.2016.1197201","volume":"17","author":"HH Wal van der","year":"2016","unstructured":"van der Wal HH, Grote Beverborg N, van Veldhuisen DJ, Voors AA, van der Meer P (2016) Pharmacotherapy for comorbidities in chronic heart failure: a focus on hematinic deficiencies, diabetes mellitus and hyperkalemia. Expert Opin Pharmacother 17(11):1527\u20131538","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"27_CR128","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ejhf.30","volume":"16","author":"VM Deursen van","year":"2014","unstructured":"van Deursen VM, Urso R, Laroche C, Damman K, Dahlstrom U, Tavazzi L et al (2014) Co-morbidities in patients with heart failure: an analysis of the European heart failure pilot survey. Eur J Heart Fail 16(1):103\u2013111","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"27_CR129","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.5665\/sleep.3840","volume":"37","author":"JP Maanen van","year":"2014","unstructured":"van Maanen JP, de Vries N (2014) Long-term effectiveness and compliance of positional therapy with the sleep position trainer in the treatment of positional obstructive sleep apnea syndrome. Sleep 37(7):1209\u20131215","journal-title":"Sleep"},{"issue":"18","key":"27_CR130","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1093\/eurheartj\/ehm328","volume":"28","author":"DJ Veldhuisen van","year":"2007","unstructured":"van Veldhuisen DJ, Dickstein K, Cohen-Solal A, Lok DJ, Wasserman SM, Baker N et al (2007) Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia. Eur Heart J 28(18):2208\u20132216","journal-title":"Eur Heart J"},{"key":"27_CR131","unstructured":"Van Veldhuisen DJ, Ponikowski P, Metra M (eds) (2016) Effect of ferric carboxymaltose on exercise capacity in patients with iron deficiency and chronic heart failure (EFFECT-HF): a randomized controlled study. American Heart Association 2016 Scientific Sessions; 16 Nov 2016; New Orleans"},{"issue":"5","key":"27_CR132","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ejheart.2006.11.001","volume":"9","author":"RL Vogels","year":"2007","unstructured":"Vogels RL, Scheltens P, Schroeder-Tanka JM, Weinstein HC (2007) Cognitive impairment in heart failure: a systematic review of the literature. Eur J Heart Fail 9(5):440\u2013449","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"27_CR133","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1410853","volume":"372","author":"MR Weir","year":"2015","unstructured":"Weir MR, Bakris GL, Bushinsky DA, Mayo MR, Garza D, Stasiv Y et al (2015) Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors. N Engl J Med 372(3):211\u2013221","journal-title":"N Engl J Med"},{"issue":"2","key":"27_CR134","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/eurheartj\/ehl419","volume":"28","author":"BD Westenbrink","year":"2007","unstructured":"Westenbrink BD, Visser FW, Voors AA, Smilde TD, Lipsic E, Navis G et al (2007) Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well. Eur Heart J 28(2):166\u2013171","journal-title":"Eur Heart J"},{"issue":"7","key":"27_CR135","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/eurjhf\/hfq061","volume":"12","author":"BD Westenbrink","year":"2010","unstructured":"Westenbrink BD, Voors AA, de Boer RA, Schuringa JJ, Klinkenberg T, van der Harst P et al (2010) Bone marrow dysfunction in chronic heart failure patients. Eur J Heart Fail 12(7):676\u2013684","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"27_CR136","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1001\/archinte.1982.00340230056012","volume":"142","author":"DP White","year":"1982","unstructured":"White DP, Zwillich CW, Pickett CK, Douglas NJ, Findley LJ, Weil JV (1982) Central sleep apnea. Improvement with acetazolamide therapy. Arch Intern Med 142(10):1816\u20131819","journal-title":"Arch Intern Med"},{"key":"27_CR137","doi-asserted-by":"crossref","unstructured":"Work Group Membership (2012) Kidney Int Suppl (2011) 2(4):281","DOI":"10.1038\/kisup.2012.39"},{"issue":"1","key":"27_CR138","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1513\/pats.200408-039MS","volume":"2","author":"EF Wouters","year":"2005","unstructured":"Wouters EF (2005) Local and systemic inflammation in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2(1):26\u201333","journal-title":"Proc Am Thorac Soc"},{"issue":"16","key":"27_CR139","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1161\/CIR.0b013e31829e8807","volume":"128","author":"CW Yancy","year":"2013","unstructured":"Writing Committee Members, Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr et al (2013) 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation 128(16):e240\u2013e327","journal-title":"Circulation"},{"issue":"2","key":"27_CR140","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00408-015-9684-z","volume":"193","author":"XB Zhang","year":"2015","unstructured":"Zhang XB, Yuan YT, Du YP, Jiang XT, Zeng HQ (2015) Efficacy of positive airway pressure on brain natriuretic peptide in patients with heart failure and sleep-disorder breathing: a meta-analysis of randomized controlled trials. Lung 193(2):255\u2013260","journal-title":"Lung"},{"issue":"8","key":"27_CR141","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/eurheartj\/ehs271","volume":"34","author":"C Zheng","year":"2013","unstructured":"Zheng C, Azcutia V, Aikawa E, Figueiredo JL, Croce K, Sonoki H et al (2013) Statins suppress apolipoprotein CIII-induced vascular endothelial cell activation and monocyte adhesion. Eur Heart J 34(8):615\u2013624","journal-title":"Eur Heart J"},{"key":"27_CR142","doi-asserted-by":"crossref","unstructured":"Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S et al (2015) Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 373(22):2117\u20132128","DOI":"10.1056\/NEJMoa1504720"}],"container-title":["Handbook of Experimental Pharmacology","Heart Failure"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2017_27","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T20:50:44Z","timestamp":1692737444000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/164_2017_27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9783319596587","9783319596594"],"references-count":142,"URL":"https:\/\/doi.org\/10.1007\/164_2017_27","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}